Neuroblastoma Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 24
SKU : PH3384
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s
What are the segments covered in Neuroblastoma Drugs Market?
The segments are By Drug Type, By Distribution Channel, and By Region.
Who are the key players in Neuroblastoma Drugs Market?
Key players are Cellectar Biosciences, INC, United Therapeutics Corporation, APEIRON Biologics AG, Teva Pharmaceutical Industries Ltd, Johnson & Johnson Services, Inc, MacroGenics, Bristol-Myers Squibb Company, Eli Lilly and Company, Marsala Biotech Inc and Pfizer Inc.
Related Reports
pharmaceuticals

Treprostinil Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 18
Starting from

$4350

pharmaceuticals

Antidepressant Drugs Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 January 16
Starting from

$4350

pharmaceuticals

Osteoporosis Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 05
Starting from

$4350

pharmaceuticals

Gastroparesis Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 11
Starting from

$4350

pharmaceuticals

Antiepileptic Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 22
Starting from

$4350

pharmaceuticals

Antiemetic Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 22
Starting from

$4350